Getting a new prescription takes time
1,2,3 It has the potential to help your body feel more balanced and comfortable while using GLP-1 medications.* 2
Behavior Change for the GLP-1 Off-Ramp The analyses support a central idea for the next phase of obesity care: durable outcomes depend not only on what happens while people are taking medication, but on what they build around it
In SURMOUNT-1, tirzepatide 15 mg produced 20.9% weight loss over 72 weeks
Pretreatment of human LADR mast cells with 100 mM of luteolin showed significant inhibition of histamine, tryptase, matrix metalloproteinase (MMP)-9, vascular endothelial growth factor (VEGF), IL-1B, IL-6, IL-8, and TNF [167]